In spite of these caveats, our findings suggest that hypoM is a prevalent epigenetic alteration in NB that affects cancer-related biological functions and specific genes relevant for NB pathogenesis, such as CCND1. Moreover, hypomethylation involves chromosomal regions recurrently altered in this malignancy. The gene discussed is CCND1; the disease is neuroblastoma.